$35M sweet spot round size
Most of their 65 investments are in rounds between $20M and $53M
2008
Xeltis raised $14M on August 14, 2023
Investors: EQT Life Sciences, DaVita Venture Group, VI Partners AG, Grand Patika and Ysios Capital
Tagworks Pharmaceuticals raised $65M on June 22, 2023
Investors: Meneldor, Gilde Healthcare, Lightstone Ventures, Oost NL and Ysios Capital
Undisclosed raised $37M on May 25, 2023
Investors: Libertatis Ergo Holding B.V., Lundbeckfonden / Lundbeck Foundation, Wake Forest Innovation Quarter, Sound Bioventures, BGV (BioGeneration Ventures) and Ysios Capital
Adcendo raised $34M on April 4, 2023
Investors: Gilde Healthcare, HealthCap, RA Capital Management, L.P., Pontifax Venture Capital, Novo Holdings and Ysios Capital
SparingVision raised $75M on September 14, 2022
Investors: RD Fund, UPMC Enterprises, JEITO and Ysios Capital
Mineralys Therapeutics, Inc. raised $118M on June 8, 2022
Investors: Sectoral Asset Management, HEALTHCOR LTD, Samsara BioCapital, Catalys Pacific, S.R. One Ltd, RA Capital Management, L.P., RTW Investments, LP and Ysios Capital
Minoryx Therapeutics raised $55M on May 31, 2022
Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., FundPlus, CDTI, Centre for the Development of Industrial Technology and Ysios Capital
ProteoDesign raised $57M on February 15, 2022
Investors: UCB Ventures, Gilde Healthcare, Asabys Partners and Ysios Capital
North Sea group raised $80M on December 17, 2021
Investors: -, Hercules Capital, Inc., BGV (BioGeneration Ventures), Forbion, venBio Partners, Sofinnova Ventures, Russia technology fund and Ysios Capital
Aura Biosciences raised undisclosed on November 3, 2021
Investors: Ysios Capital